The two organizations join forces to develop pioneering AI-based solutions for efficient chemical synthesis planning that accelerates the development of new drugs.
CAS, a division...
At the Experimental Nuclear Magnetic Resonance Conference, Bruker announces innovations for NMR spectroscopy in life science, pharma, and cleantech research to enable discoveries in functional structural...
M2GEN, an oncology bioinformatics company with the most advanced lifetime-consented clinicogenomic data to accelerate medical product discovery, announced it is rebranding, changing the company's...
PsychoGenics Inc, a leader in AI-enabled phenotypic drug discovery and preclinical CRO services, announced that it has launched eCube, a novel pharmaco-electroencephalography platform to...
